SPTLC3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.295800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.314000E-01
Normal-vs-Stage2
6.705400E-01
Normal-vs-Stage3
4.940400E-01
Normal-vs-Stage4
6.174200E-01
Stage1-vs-Stage2
5.039400E-01
Stage1-vs-Stage3
2.211400E-01
Stage1-vs-Stage4
6.665600E-01
Stage2-vs-Stage3
2.117000E-01
Stage2-vs-Stage4
8.081400E-01
Stage3-vs-Stage4
1.644830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.366600E-01
Normal-vs-AfricanAmerican
5.336800E-01
Normal-vs-Asian
8.343600E-01
Caucasian-vs-AfricanAmerican
5.091800E-01
Caucasian-vs-Asian
3.261600E-01
AfricanAmerican-vs-Asian
2.038400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.467800E-01
Normal-vs-Female
7.211800E-01
Male-vs-Female
9.684600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.191800E-01
Normal-vs-Age(41-60Yrs)
5.535800E-01
Normal-vs-Age(61-80Yrs)
9.080000E-01
Normal-vs-Age(81-100Yrs)
5.856600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.372200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.519200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.488000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.517700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.941200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.186800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.342000E-01
Normal-vs-Daily Drinker
9.877600E-01
Normal-vs-Weekly Drinker
8.054600E-01
Normal-vs-Occasional Drinker
6.265600E-01
Normal-vs-Social Drinker
5.241200E-01
Non Drinker-vs-Daily Drinker
5.454200E-01
Non Drinker-vs-Weekly Drinker
2.537600E-01
Non Drinker-vs-Occasional Drinker
4.132800E-01
Non Drinker-vs-Social Drinker
3.130400E-01
Daily Drinker-vs-Weekly Drinker
6.887400E-01
Daily Drinker-vs-Occasional Drinker
2.814000E-01
Daily Drinker-vs-Social Drinker
2.207200E-01
Weekly Drinker-vs-Occasional Drinker
1.730360E-01
Weekly Drinker-vs-Social Drinker
1.117790E-01
Occasional Drinker-vs-Social Drinker
8.748200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.130600E-01
Normal-vs-Grade 2
1.382350E-01
Normal-vs-Grade 3
6.716500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.095700E-02
Grade 1-vs-Grade 3
2.780100E-03
Grade 1-vs-Grade 4
3.130600E-01
Grade 2-vs-Grade 3
3.365500E-02
Grade 2-vs-Grade 4
1.382350E-01
Grade 3-vs-Grade 4
6.716500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.458800E-01
Normal-vs-NonDiabetic
7.803400E-01
Diabetic-vs-NonDiabetic
4.673600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.053600E-01
Normal-vs-NoPancreatitis
7.563600E-01
Pancreatitis-vs-NoPancreatitis
3.236400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.953200E-01
Normal-vs-N1
6.133600E-01
N0-vs-N1
2.289200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.082800E-01
Normal-vs-TP53-NonMutant
6.343200E-01
TP53-Mutant-vs-TP53-NonMutant
9.828400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
